{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:30:47Z","timestamp":1777987847302,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT \/PR31156\/MED\/30\/2019"],"award-info":[{"award-number":["BT \/PR31156\/MED\/30\/2019"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","award":["R\/Dev\/D\/IoE\/Incentive\/2022\\u201323\/47674"],"award-info":[{"award-number":["R\/Dev\/D\/IoE\/Incentive\/2022\\u201323\/47674"]}],"id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","award":["SRICC\/RJP- PDF \/2023\\u201324\/8208"],"award-info":[{"award-number":["SRICC\/RJP- PDF \/2023\\u201324\/8208"]}],"id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153115","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:56:01Z","timestamp":1765814161000},"page":"153115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches"],"prefix":"10.1016","volume":"796","author":[{"given":"Pratistha","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5572-0000","authenticated-orcid":false,"given":"Vinay Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-6086","authenticated-orcid":false,"given":"Malkhey","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.153115_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000468","article-title":"Chronic myeloid leukemia in 2020","volume":"4","author":"Hehlmann","year":"2020","journal-title":"HemaSphere"},{"key":"10.1016\/j.bbrc.2025.153115_bib2","first-page":"1619","article-title":"Molecular biology of bcr-abl1\u2013positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood, Journal of the American Society of Hematology"},{"key":"10.1016\/j.bbrc.2025.153115_bib3","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.153115_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5306\/wjco.v12.i2.69","article-title":"Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: a literature review","volume":"12","author":"Sampaio","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.153115_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.153115_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.37349\/etat.2022.00083","article-title":"Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it","volume":"3","author":"Sulkshane","year":"2022","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.bbrc.2025.153115_bib7","first-page":"25","article-title":"Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma","volume":"28","author":"Fleischer","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2025.153115_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2025.153115_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41418-018-0225-1","article-title":"Mcl-1 and Bcl-xL are essential for survival of the developing nervous system","volume":"26","author":"Fogarty","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2025.153115_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.153115_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.153115_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1101\/gad.215855.113","article-title":"Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction","volume":"27","author":"Wang","year":"2013","journal-title":"Gene Dev."},{"key":"10.1016\/j.bbrc.2025.153115_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100672","article-title":"Targeting MCL-1 in hematologic malignancies: rationale and progress","volume":"44","author":"Wei","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2025.153115_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-6-232","article-title":"Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction","volume":"6","author":"Schulze-Bergkamen","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.153115_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1226289","article-title":"Targeting MCL-1 protein to treat cancer: opportunities and challenges","volume":"13","author":"Tantawy","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.153115_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2025.153115_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"Van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.153115_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2018.11.004","article-title":"BH3-mimetic drugs: blazing the trail for new cancer medicines","volume":"34","author":"Merino","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.153115_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1873-3468.12497","article-title":"Discovery and biological characterization of potent myeloid cell leukemia\u20101 inhibitors","volume":"591","author":"Lee","year":"2017","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.bbrc.2025.153115_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.6026\/97320630015179","article-title":"Molecular docking analysis of candidate compounds derived from medicinal plants with type 2 diabetes mellitus targets","volume":"15","author":"Singh","year":"2019","journal-title":"Bioinformation"},{"key":"10.1016\/j.bbrc.2025.153115_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100193","article-title":"Panchvalkal (polyherbal formulation) mitigates STZ induced type 2 DM by modulating the expression of hexokinase (HX), lactate dehydrogenase (LDH), triphosphate isomerase (TPI)","volume":"2","author":"Singh","year":"2022","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.bbrc.2025.153115_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5958\/2321-7111.2017.00012.9","article-title":"Molecular docking studies of medicinal compounds against aldose reductase drug target for treatment of type 2 diabetes","volume":"5","author":"Singh","year":"2017","journal-title":"Int. J. Bioinf. Biol. Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib23","series-title":"Natural Products for Treatment of Chronic Myeloid Leukemia, Anti-cancer Drugsnature, Synthesis and Cell","first-page":"1","author":"Khajapeer","year":"2016"},{"key":"10.1016\/j.bbrc.2025.153115_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69722-4","article-title":"Anticancer properties of Tulbaghia violacea regulate the expression of p53-dependent mechanisms in cancer cell lines","volume":"10","author":"Motadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/nu11051010","article-title":"Natural products and acute myeloid leukemia: a review highlighting mechanisms of action","volume":"11","author":"Hwang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2025.153115_bib26","article-title":"Chemical dissection of selective myeloid leukemia-1 inhibitors: how they were found and evolved","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118079","article-title":"Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present)","author":"Chen","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib28","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1021\/acs.jmedchem.3c01998","article-title":"Targeting myeloid leukemia-1 in cancer therapy: advances and directions","volume":"67","author":"Deng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib30","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"Burley","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.153115_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.4213","article-title":"RCSB Protein Data Bank: celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D","volume":"31","author":"Burley","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib32","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.153115_bib33","first-page":"396","article-title":"Virtual screening in lead discovery and optimization","volume":"7","author":"Jain","year":"2004","journal-title":"Curr. Opin. Drug Discov. Dev"},{"key":"10.1016\/j.bbrc.2025.153115_bib34","series-title":"Drug Designing in Discovery Studio","author":"Jejurikar","year":"2021"},{"key":"10.1016\/j.bbrc.2025.153115_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bbrc.2025.153115_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib37","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib38","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.153115_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T","article-title":"High throughput docking for library design and library prioritization","volume":"43","author":"Diller","year":"2001","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.bbrc.2025.153115_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411671","article-title":"MD\u2013ligand\u2013receptor: a high-performance computing tool for characterizing ligand\u2013receptor binding interactions in molecular dynamics trajectories","volume":"24","author":"Pieroni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib42","doi-asserted-by":"crossref","first-page":"gzac001","DOI":"10.1093\/protein\/gzac001","article-title":"The stability and dynamics of computationally designed proteins","volume":"35","author":"Gonzalez","year":"2022","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbrc.2025.153115_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/srep34984","article-title":"Structural insights into conformational stability of both wild-type and mutant EZH2 receptor","volume":"6","author":"Aier","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib44","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/bioinformatics\/bty879","article-title":"farPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM\/PB (GB) SA methods","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2025.153115_bib45","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/acs.jcim.0c00057","article-title":"Improving protein-ligand docking results with high-throughput molecular dynamics simulations","volume":"60","author":"Guterres","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.153115_bib46","doi-asserted-by":"crossref","first-page":"24274","DOI":"10.1021\/acsomega.2c01475","article-title":"Protein model quality estimation using molecular dynamics simulation","volume":"7","author":"Kurniawan","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2025.153115_bib47","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jcim.6b00305","article-title":"Exploring protein stability by comparative molecular dynamics simulations of homologous hyperthermophilic, mesophilic, and psychrophilic proteins","volume":"56","author":"Khan","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.153115_bib48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.coph.2010.09.016","article-title":"Molecular dynamics simulations of protein dynamics and their relevance to drug discovery","volume":"10","author":"Salsbury","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.153115_bib49","article-title":"Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.153115_bib50","series-title":"Cancer Cell Culture: Methods and Protocols","first-page":"237","article-title":"Cell sensitivity assays: the MTT assay","author":"Van Meerloo","year":"2011"},{"key":"10.1016\/j.bbrc.2025.153115_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00169-7","article-title":"Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization","volume":"118","author":"Gribble","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bbrc.2025.153115_bib52","first-page":"974","article-title":"The K562 chronic myeloid leukemia cell line undergoes apoptosis in response to interferon-alpha","volume":"83","author":"Luchetti","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2025.153115_bib53","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/jm501984f","article-title":"Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design","volume":"58","author":"Burke","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib54","article-title":"Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol.(Mosc.)"},{"key":"10.1016\/j.bbrc.2025.153115_bib56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"Ausaf Ali","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/prot.26313","article-title":"Insights into protein\u2013DNA interactions from hydrogen bond energy\u2010based comparative protein\u2013ligand analyses","volume":"90","author":"Malik","year":"2022","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.bbrc.2025.153115_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s42004-019-0205-5","article-title":"An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder","volume":"2","author":"Majewski","year":"2019","journal-title":"Commun. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/ct9005745","article-title":"Relation between free energy landscapes of proteins and dynamics","volume":"6","author":"Maisuradze","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2025.153115_bib60","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.3390\/plants10122749","article-title":"Phytochemistry, pharmacological properties, and recent applications of Ficus benghalensis and Ficus religiosa","volume":"10","author":"Murugesu","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.bbrc.2025.153115_bib61","first-page":"560","article-title":"Phytopharamacology and pharmacognostic properties of Ficus benghalensis-A review","volume":"2","author":"Chaudhary","year":"2015","journal-title":"Int. J. Pharmacogn. Phytochem. Res."},{"key":"10.1016\/j.bbrc.2025.153115_bib62","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s40200-020-00651-9","article-title":"Integration of in silico, in vitro and ex vivo pharmacology to decode the anti-diabetic action of Ficus benghalensis L. bark","volume":"19","author":"Khanal","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.bbrc.2025.153115_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2023.100134","article-title":"Ficus benghalensis L.(Moraceae): a review on ethnomedicinal uses, phytochemistry and pharmacological activities","volume":"6","author":"Logesh","year":"2023","journal-title":"Current Research in Biotechnology"},{"key":"10.1016\/j.bbrc.2025.153115_bib64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/jbcpp-2020-0455","article-title":"Siswandono, Design of gossypetin derivatives based on naturally occurring flavonoid in Hibiscus sabdariffa and the molecular docking as antibacterial agents","volume":"32","author":"Diyah","year":"2021","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.153115_bib65","first-page":"67","article-title":"Antioxidant potential and in vitro cytotoxicity study of Saraca indica extract on lead-induced toxicity in HepG2 and HEK293 cell lines","volume":"14","author":"Shivhare","year":"2023","journal-title":"Indian Journal of Natural Products and Resources (IJNPR)."},{"key":"10.1016\/j.bbrc.2025.153115_bib66","article-title":"Evolution of tolbutamide in the treatment of diabetes mellitus","volume":"2","author":"Saha","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2025.153115_bib67","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jm500010b","article-title":"3-Substituted-N-(4-hydroxynaphthalen-1-yl) arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation","volume":"57","author":"Abulwerdi","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib68","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1200\/JCO.1989.7.11.1733","article-title":"Clinical pharmacology of a novel diarylsulfonylurea anticancer agent","volume":"7","author":"Taylor","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.153115_bib69","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.18632\/oncotarget.2483","article-title":"Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis","volume":"5","author":"Qi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.153115_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215611","article-title":"Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression","volume":"536","author":"Chen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.153115_bib71","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/1535-7163.MCT-18-1181","article-title":"Glibenclamide targets sulfonylurea receptor 1 to inhibit p70S6K activity and upregulate KLF4 expression to suppress non-small cell lung carcinoma","volume":"18","author":"Xu","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2025.153115_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep23690","article-title":"Structure based docking and molecular dynamic studies of plasmodial cysteine proteases against a South African natural compound and its analogs","volume":"6","author":"Musyoka","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153115_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.153115_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002002","article-title":"The free energy landscape of small molecule unbinding","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbrc.2025.153115_bib75","article-title":"Imatinib in chronic myeloid leukemia: an overview","volume":"6","author":"Sacha","year":"2014","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"key":"10.1016\/j.bbrc.2025.153115_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4274\/tjps.galenos.2018.49389","article-title":"Effects of glycyrrhetic acid on human chronic myelogenous leukemia cells","volume":"17","author":"Ciftci","year":"2020","journal-title":"Turkish Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.bbrc.2025.153115_bib77","first-page":"78","article-title":"Effect of homoharringtonine on expression of NF-\u03baB and BCL-2 proteins in K562 cells, Zhongguo shi yan xue ye xue za zhi","volume":"21","author":"Ye","year":"2013"},{"key":"10.1016\/j.bbrc.2025.153115_bib78","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3892\/etm.2017.4443","article-title":"Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro","volume":"13","author":"Husaini","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2025.153115_bib79","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2147\/DDDT.S132092","article-title":"Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines","author":"Xin","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrc.2025.153115_bib80","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7150\/ijbs.14878","article-title":"In vitro antileukemia activity of ZSTK474 on K562 and multidrug resistant K562\/A02 cells","volume":"12","author":"Zhou","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2025.153115_bib81","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.153115_bib82","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/jsre.1993.1185","article-title":"Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyte","volume":"55","author":"Blumberg","year":"1993","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbrc.2025.153115_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108427","article-title":"Discovery of natural MCL1 inhibitors using pharmacophore modelling, QSAR, docking, ADMET, molecular dynamics, and DFT analysis","volume":"117","author":"Das","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.153115_bib84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/07391102.2023.2281637","article-title":"Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies","volume":"43","author":"Alzain","year":"2025","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:17:43Z","timestamp":1773904663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25018315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":84,"alternative-id":["S0006291X25018315"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153115","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153115"}}